Benchmark Raises Price Target on Bio-Reference Laboratories (BRLI) Due to Solid Q4 Results and FY12 Outlook
Go back to Benchmark Raises Price Target on Bio-Reference Laboratories (BRLI) Due to Solid Q4 Results and FY12 Outlook| Bio-Reference Labs, Inc. (NASDAQ: BRLI) | Delayed: 4.70 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.70 | 52 Week High | $47.49 | |||
| Open | $0.01 | 52 Week Low | $26.32 | |||
| Day High | $4.70 | P/E | 2.85 | |||
| Day Low | $4.70 | EPS | $1.65 | |||
| Volume | 525 | |||||
